Loading company…
Taiwan Universe BioMedicine develops vaccines for enteroviruses and influenza.
Founded in 2024 in Taiwan, Taiwan Universe BioMedicine develops bivalent enterovirus and seasonal influenza VLP vaccines using insect cell systems. The company targets healthcare providers, public agencies and research institutions. In August 2025, it received USD 2.000 mn in SEED funding led by Mosaic Venture Lab and supported by National Development Fund. Founder Dr. Min-Shi Lee has a biotechnology background.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Taiwan Universe BioMedicine Inc.? This is my company